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Abstract
Background: Gonadotropin-releasing hormone (GnRH) and kisspeptin in the hypothalamus are thought to be
crucial components of the hypothalamic-pituitary-gonadal (HPG) axis and maintain reproductive function. These
neuropeptides are also expressed in the placenta, where they may contribute to placental physiology. In this study,
we examined how these peptides are regulated within the placenta.
Methods: We used primary cultures of placental tissue from rats of 16–18 days gestation. After stimulation with
estradiol, GnRH, kisspeptin, and neurokinin B (NKB), changes in placental GnRH, kisspeptin, and human chorionic
gonadotropin (hCG) mRNA expression were evaluated by real-time quantitative RT-PCR analysis.
Results: Immunocytochemical analysis showed that rat placental cells contained cells expressing kisspeptin or
GnRH. GnRH and kisspeptin mRNA expression was significantly increased in placental cells in the presence of
estradiol; NKB mRNA expression was also stimulated by estradiol. Stimulation of the cells with kisspeptin failed to
stimulate GnRH mRNA expression. Conversely, both GnRH itself and NKB increased GnRH mRNA expression.
Kisspeptin mRNA expression was not increased by kisspeptin itself; however, GnRH and NKB significantly increased
kisspeptin mRNA expression. hCG expression was increased in the presence of estradiol. In addition, kisspeptin,
GnRH, and NKB could stimulate the expression of hCG mRNA in placental cells.
Conclusions: Our experiments using primary cultures of rat placental cells showed that GnRH, kisspeptin, and NKB
expression was enhanced by estradiol, and unlike in the hypothalamus, kisspeptin did not control the expression of
GnRH in placental cells. NKB might be located upstream of kisspeptin and GnRH, and these neuropeptides might
be involved in the induction of hCG expression in placental cells.
Background
After the discovery of inactivating mutations in the kis-
speptin receptor of patients with idiopathic hypogonado-
tropic hypogonadism [1, 2], hypothalamic kisspeptin is
now defined to be located upstream of gonadotropin-
releasing hormone (GnRH)-expressing neurons and
accepted as a crucial regulator of the hypothalamic-
pituitary-gonadal (HPG) axis. Kisspeptin is a powerful
stimulator of GnRH, and GnRH induces the secretion of
gonadotropin from the anterior pituitary and maintains
reproductive function by stimulating follicular growth
and the synthesis of sex steroids [3].
GnRH and kisspeptin are expressed not only in hypo-
thalamic neurons but also in a number of peripheral or-
gans. Extrahypothalamic GnRH and its receptors are
present in various tissues including the ovary, testis,
prostate, and mammary gland [4]. The existence of a
GnRH-like peptide in human placenta was first reported
by Gibbons et al. and it was found to be identical to
GnRH in the hypothalamus [5]. A receptor for GnRH
was also identified in human placenta [6]. GnRH has
been detected in extravillous cytotrophoblasts in human
placenta during the 1st trimester [7], and the existence
of GnRH receptors in these cells was also reported [8].
GnRH in placental tissues has been suggested to regulate
the invasive differentiation of primary extravillous cytotro-
phoblasts by modulating the matrix metalloprotease or
plasminogen system [9, 10]. Placental GnRH is also
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suggested to be involved in the autocrine/paracrine regu-
lation of chorionic gonadotropin biosynthesis [11, 12].
The expression of kisspeptin and its receptor has also
been demonstrated in a variety of tissues; kisspeptin is
mainly expressed in the placenta, with much lower ex-
pression levels in the liver, pancreas, small intestine,
testis, and brain [13]. Kisspeptin and its receptors are
expressed strongly in the placenta, and this observation
is paralleled by the finding that the plasma levels of kis-
speptin are high in pregnant women [14]. In human
placenta, kisspeptin mRNA is expressed in the syncy-
tiotrophoblast, which develops from the fusion of
cytotrophoblasts and represents the placental interface
with the maternal circulatory system. The maternal
decidua is devoid of kisspeptin. Kisspeptin receptors
are expressed in the syncytiotrophoblast, villous, and
invading extravillous trophoblasts [15]. Thus, kisspep-
tin and its receptor signaling have been identified as
inhibitory regulators of trophoblast invasion. It was
reported that the synthesis of kisspeptin inhibited
extravillous cytotrophoblast migration without affect-
ing their proliferation [15].
The physiological importance of GnRH and kisspeptin
signaling are well understood as positive regulators of
the HPG axis, in which GnRH is under the control of
kisspeptin. Conversely, it unknown whether there is any
relationship between the expression of GnRH and kis-
speptin in the placenta. In this study, we used primary




The following chemicals and reagents were obtained
from the indicated sources: fetal bovine serum (FBS)
(GIBCO, Invitrogen, Carlsbad, CA); Dulbecco’s modified
Eagle’s medium (DMEM), water soluble β-estradiol (E2),
GnRH, and penicillin-streptomycin (Sigma-Aldrich Co.,
St. Louis, MO); kisspeptin (Kp-10) (ANA SPEC, Fremont,
CA); neurokinin B (NKB) (Sigma-Aldrich Co., St. Louis,
MO); and DNase I (Promega Co., Madison, WI).
Placental cell culture
Placental tissue was processed to obtain trophoblast pri-
mary cultures as described previously [16, 17]. Briefly,
term placental tissue obtained from rats of 16–18 days
gestation was cut into small pieces and digested for
30 min with 0.25 % trypsin and DNase I (300 U/mL) at
37 °C with gentle agitation. Then, the suspension was fil-
tered through a cell strainer with 100-μm pores to re-
move undigested material. For washing, the supernatant
was collected and resuspended in DMEM and centri-
fuged at 500 × g for 5 min, and the pelleted cells were
washed once more. Finally, the suspension was layered
over a Percoll solution (Percoll gradient was made from
70–5 % Percoll in 5 % steps of 2 ml each by dilution of
90 % Percoll with Hank’s balanced salt solution) and
centrifuged at 1000 × g for 20 min. The middle layer was
removed and washed with DMEM. Pennington et al.
confirmed a relatively pure trophoblast cell population
could be obtained from placental tissue using this proto-
col [16]. The isolated trophoblast cells were cultured in
high-glucose DMEM containing 10 % heat-inactivated
FBS and 1 % penicillin-streptomycin at 37 °C in a hu-
midified atmosphere of 5 % CO2 in air. The protocol was
approved by the committee of the Experimental Animal
Center for Integrated Research at Shimane University.
Immunocytochemistry
The cells were fixed on coverslips by 10 min methanol
treatment at −20 °C. After 10 min of dehydration at
25 °C, the cells were treated with 0.2 % Triton X-100
in phosphate-buffered saline for permeabilization. Non-
specific antibody binding was blocked by preincubation
with 1 % albumin, followed by an overnight incubation
at 4 °C with an anti-kisspeptin antibody (1:500 dilu-
tion) (Millipore, Billerica, MA) and anti-GnRH 1 anti-
body (1:50 dilution) (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA). To visualize kisspeptin and GnRH, the
cells were stained with secondary antibodies according to
the manufacturer’s instructions for the use of a Histofine
SAB-PO (MULTI) Kit (Nichirei Bioscience, Inc., Tokyo,
Japan). The biotinylated secondary antibodies were
coupled to streptavidin-biotinylated horseradish peroxid-
ase and the reaction was visualized using diaminobenzi-
dine as a chromogen. Chemiluminescence images of the
cells were obtained with a microscope (Olympus BX41;
Olympus, Tokyo, Japan).
RNA preparation, reverse transcription, and real-time
quantitative reverse transcription-polymerase chain
reaction
Total RNA from placental cells was extracted using
TRIzol-S (Invitrogen Life Technologies, Carlsbad, CA)
according to the manufacturer’s instructions. To obtain
cDNA, 1.0 μg total RNA was reverse transcribed using an
oligo-dT primer (Promega, Madison, WI) and prepared
using a First-Strand cDNA Synthesis Kit (Invitrogen Life
Technologies, Carlsbad, CA) in reverse transcription (RT)
buffer. The preparation was supplemented with 10 mM
dithiothreitol, 1 mM of each dNTP, and 200 U RNase in-
hibitor/human placenta ribonuclease inhibitor (Code No.
2310; Takara, Tokyo, Japan) in a final volume of 10 μL.
The reaction was incubated at 37 °C for 60 min. Quantifi-
cation of GnRH, kisspeptin, and human chorionic go-
nadotropin (hCG) mRNA was obtained through real-time
quantitative polymerase chain reaction (PCR; ABI Prism
7000; Perkin Elmer Applied Biosystems, Foster City, CA)
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following the manufacturer’s protocol (User Bulletin No. 2)
and utilizing a Universal Probe Library Probe and Fast Start
Master Mix (Roche Diagnostics, Mannheim, Germany).
Using specific primers for GnRH (forward: 5′-ACTGT
GTGTTTGGAAGGCTGC-3′ and reverse: 5′-TTCCAG
AGCTCCTCGCAGATC-3′), kisspeptin (forward: 5′-AT
GATCTCGCTGGCTTCTTGG-3′ and reverse: 5′-GGTT
CACCACAGGTGCCATTTT-3′), NKB (forward: 5′-CC
AGTGTGTGAGGGGAGCA-3′ and reverse: 5′-TCCAG
AGATGAGTGGCTTTTGA-3′), and hCG (forward: 5′-
ACATGGGCATCCAAGGAGCCGCTT-3′ and reverse:
5′-CGCACATCGCGGTAGTTGCACA-3′), the simul-
taneous measurement of mRNA and GAPDH permitted
normalization of the amount of cDNA added per sample.
For each set of primers, a no template control was in-
cluded. Thermal cycling conditions were as follows:
10 min denaturation at 95 °C, followed by 40 cycles of
95 °C for 15 s and 60 °C for 1 min. The crossing thresh-
old was determined using PRISM 7000 software, and
postamplification data were analyzed using the delta-
delta CT method in Microsoft Excel.
Statistical analysis
All experiments were repeated independently at least
three times, and each experiment was performed in du-
plicate for each experimental group. Data are expressed
as the mean ± standard error of the mean (SEM). Statis-
tical analysis was performed using one-way analysis of
variance, followed by Newman-Keuls multiple compari-
son test.
Results
GnRH and kisspeptin expression in rat placental cells
Primary cultures of rat placental cells collected from rats
of 16–18 days gestation were cultured. The cultured pla-
cental cells contained several types of cells, but the ma-
jority of cells were considered to be trophoblasts
according to the method used for cell collection. Immu-
nostaining showed the expression of GnRH and kisspep-
tin in rat placental cells (Fig. 1).
Effect of estradiol on GnRH, kisspeptin, and NKB mRNA
expression
We examined whether GnRH and kisspeptin, which are
expressed in placental cells, were regulated by estradiol.
By treatment with 10 μM estradiol for 24 h, GnRH
mRNA expression was significantly increased by 2.08 ±
0.43-fold compared to non-stimulated cells. One micro-
molar estradiol slightly increased GnRH mRNA levels,
but not significantly so (Fig. 2a). Similarly, 10 μM estra-
diol, but not 1 μM, significantly increased kisspeptin
mRNA expression by 3.30 ± 0.70-fold compared to non-
stimulated cells (Fig. 2b). In this series of experiment, we
also examined NKB expression, which is coexpressed in
kisspeptin-producing neurons in the arcuate nucleus
(ARC) of the rat hypothalamus and positively regulates
their activity [18, 19]. NKB expression was also stimu-
lated in the presence of 10 μM estradiol by 1.85 ± 0.03-
fold compared to non-stimulated cells (Fig. 2c).
Effect of kisspeptin on GnRH mRNA expression
Increasing evidence supports the hypothesis that kisspep-
tin controls gonadotropin secretion by stimulating GnRH-
positive neurons in the hypothalamus. Next, we examined
the effect of kisspeptin on GnRH-producing placental
cells. Kisspeptin failed to stimulate GnRH mRNA expres-
sion in placental cells. GnRH itself slightly increased
GnRH mRNA expression by 1.64 ± 0.3-fold in these cells
compared to non-stimulated cells. In addition, NKB
slightly, but significantly, increased GnRH mRNA expres-
sion by 1.67 ± 0.18-fold compared to non-stimulated cells
(Fig. 3).
Kisspeptin expression is increased by stimulation with
GnRH and NKB
Next, we examined how kisspeptin mRNA is regu-
lated in placental cells. Kisspeptin itself did not mod-
ify its own gene expression. On the contrary, GnRH
significantly increased kisspeptin mRNA expression by
2.27 ± 0.36-fold compared to non-stimulated cells.
NKB also stimulated kisspeptin expression in placental
Fig. 1 Staining of rat placental cells for GnRH and kisspeptin. Cultures of placental cells from rats at 18 weeks of gestation were immunostained
using anti-kisspeptin (Kp-10) (b) and anti-GnRH (c) antibodies. The negative control is shown in (a) (control). The colors were developed by
streptavidin-biotinylated horseradish peroxidase. Magnification, ×20
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cells by 2.95 ± 0.75–fold compared to non-stimulated cells
(Fig. 4).
hCG gene expression is enhanced by kisspeptin, GnRH,
and NKB
Finally, we examined the expression of hCG mRNA in
placental cells. Before this experiment, we confirmed that
hCG mRNA was amplified by RT-PCR using specific
primers for human hCG in rat placental cells (data not
shown). Similar to its effects on GnRH and kisspeptin,
10 μM estradiol significantly increased hCG mRNA ex-
pression in placental cells (Fig. 5a). Both kisspeptin and
GnRH significantly stimulated hCG expression by
1.40 ± 0.17-fold and 1.49 ± 0.25-fold, respectively, com-
pared to non-stimulated cells. In addition, NKB in-
creased hCG mRNA expression by 2.51 ± 0.37-fold
compared to non-stimulated cells, which was significantly
higher than the effects of kisspeptin and GnRH (Fig. 5b).
Discussion
Accumulating evidence supports the concept that the re-
productive neuroendocrine axis is centrally regulated by
inputs from kisspeptin-expressing neurons to GnRH-
expressing neurons, which subsequently regulate the re-
lease of luteinizing hormone (LH) and follicle-stimulating
hormone from the anterior pituitary. The direct and po-
tent actions of hypothalamic kisspeptin at the level of
GnRH-positive neurons have been documented [20, 21],
and kisspeptin can reportedly increase GnRH mRNA ex-
pression in GnRH-secreting neuronal cells [22, 23].
In addition, estradiol is one of the most important reg-
ulators of the neuronal activity of kisspeptin and GnRH.
Previous studies provided evidence that the estradiol-
dependent induction of kisspeptin mRNA in the antero-
ventral periventricular nucleus (AVPV) may play a role
in mediating the preovulatory GnRH/LH surge in female
animals [24, 25]. Conversely, the expression levels of
Fig. 2 Effect of estradiol on GnRH, kisspeptin, and NKB expression in placental cells. Primary cultures of rat placental cells were cultured in the
presence or absence (control) of 1 μM or 10 μM estradiol (E2) for 24 h. Then, GnRH (a), kisspeptin (b), and NKB (c) mRNA levels were measured
by quantitative real-time PCR after mRNA extraction and reverse transcription. Samples for each experimental group were run in duplicate and
normalized to GAPDH mRNA levels as a housekeeping gene. Results are expressed as fold stimulation over the unstimulated group/control. Values
are the mean ± SEM of fold stimulation taken from independent experiments. **P < 0.01, *P < 0.05 vs. control
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kisspeptin mRNA in the ARC increase upon gonadec-
tomy and decrease upon steroid replacement in mice
[26]. That is, estradiol, kisspeptin, and GnRH, which are
present in the hypothalamus, affect each other and
modulate their functions.
In addition, we examined the effect of NKB in the
present study. Inactivating mutations in human genes en-
coding NKB (TAC3) and neurokinin 3 receptor cause
idiopathic hypogonadotropic hypogonadism [27, 28], and
low circulating levels of gonadotropins can be rescued by
the administration of exogenous GnRH [29]. Kisspeptin
neurons within the ARC are referred to as KNDy neurons
because kisspeptin, NKB, and dynorphin are coexpressed
in these neurons [18], and NKB has been suggested to act
autosynaptically or transsynaptically to regulate kisspeptin
secretion [30]. These observations suggest that NKB is
Fig. 3 Effect of kisspeptin, GnRH, and NKB on GnRH mRNA expression in placental cells. Primary cultures of rat placental cells were treated with
kisspeptin (100 nM), GnRH (100 nM), or NKB (100 nM) for 24 h. Then, GnRH mRNA levels were measured by quantitative real-time PCR after mRNA
extraction and reverse transcription. Samples for each experimental group were run in duplicate and normalized to GAPDH mRNA levels as a
housekeeping gene. Results are expressed as fold stimulation over the unstimulated group/control. Values are the mean ± SEM of fold stimulation
taken from independent experiments. **P < 0.01, *P < 0.05 vs. control
Fig. 4 Effect of kisspeptin, GnRH, and NKB on kisspeptin mRNA expression in placental cells. Primary cultures of rat placental cells were treated
with kisspeptin (100 nM), GnRH (100 nM), or NKB (100 nM) for 24 h. Then, kisspeptin mRNA levels were measured by quantitative real-time PCR
after mRNA extraction and reverse transcription. Samples for each experimental group were run in duplicate and normalized to GAPDH mRNA
levels as a housekeeping gene. Results are expressed as fold stimulation over the unstimulated group/control. Values are the mean ± SEM of fold
stimulation taken from independent experiments. **P < 0.01, *P < 0.05 vs. control
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located upstream of kisspeptin in the newly recognized
HPG axis.
Previous reports demonstrated the presence of GnRH
and kisspeptin in peripheral placental tissues [7, 15], but it
remains unknown whether the GnRH expressed in pla-
cental cells is under the control of kisspeptin. To examine
the physiological significance of extra-hypothalamic GnRH
and kisspeptin, the current experiments were conducted. In
primary cultures of rat placental cells, both kisspeptin- and
GnRH-immunoreactive cells were detected using specific
antibodies. According to the protocol used to obtain tro-
phoblasts from the rat placenta [16, 17], the majority of
these placental cells were considered to be trophoblasts.
First, we examined the effect of estradiol on GnRH
and kisspeptin expression in placental cells, and found
that the expression of both GnRH and kisspeptin in pla-
cental cells responded to and was increased by estradiol
(Fig. 2a and b). A previous report demonstrated that
GnRH mRNA expression was increased in hypothalamic
GnRH-positive neurons of male chickens after castra-
tion, and this increase was prevented by treatment with
estrogen [31]. In addition, an experiment using an im-
mortalized GnRH-producing cell model demonstrated
that estradiol treatment reduces GnRH mRNA expres-
sion at the single cell level [22]. These observations sug-
gest the inhibitory control of GnRH by estradiol exists
in the hypothalamus in an indirect or direct manner. As
placental GnRH was upregulated by estradiol, the nature
of GnRH-producing cells within the placenta might be
distinct from hypothalamic GnRH-positive neurons.
Whereas, although kisspeptin expression in hypothal-
amic kisspeptin-positive neurons is regulated by estro-
gen, the actions of estrogen largely differ according to
the population of kisspeptin-expressing neurons exam-
ined. In rodents, kisspeptin expression in kisspeptin-
positive neurons within the AVPV is up-regulated by
treatment with estrogen [32]. Conversely, in kisspeptin-
positive neurons within the ARC that co-express NKB
and dynorphin (i.e., KNDy neurons), estrogen treatment
decreases kisspeptin mRNA levels [24, 32]. As placental
kisspeptin expression was upregulated by estradiol,
kisspeptin-producing cells within the placenta might
have similar characteristics to kisspeptin-expressing neu-
rons within the AVPV in rodents. In addition, NKB ex-
pression in placental cells was also upregulated by
estradiol (Fig. 2c). Considering the facts that KNDy neu-
rons expressing NKB in the ARC were negatively regu-
lated by estradiol [32] and NKB is a stimulator of
kisspeptin release [30], NKB-expressing cells in the pla-
centa might have distinct characteristics from those in
the hypothalamus.
It is obvious that kisspeptin is a gatekeeper of
reproduction owing to its central role in the HPG axis,
and many data have led to the general concept that
kisspeptin-positive neurons activate GnRH-positive neu-
rons in the hypothalamus [33, 34]. Studies of the role of
kisspeptin on GnRH-positive neurons have already fo-
cused on the cellular secretion of GnRH, which was
Fig. 5 hCG expression by estradiol and neuropeptides. Primary cultures of rat placental cells were cultured in the presence or absence (control)
of estradiol (E2) (a), kisspeptin (100 nM), GnRH (100 nM), or NKB (100 nM) (b) for 24 h. Then, hCG mRNA levels were measured by quantitative
real-time PCR after mRNA extraction and reverse transcription. Samples for each experimental group were run in duplicate and normalized to
GAPDH mRNA levels as a housekeeping gene. Results are expressed as fold stimulation over the unstimulated group/control. Values are the
mean ± SEM of fold stimulation taken from independent experiments. **P < 0.01, *P < 0.05 vs. control
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determined indirectly by measuring LH release [35, 36].
In addition, GnRH gene expression is also reportedly
regulated in response to kisspeptin in GnRH-producing
cell models [22, 37]. In our primary cultures of rat pla-
cental cells, kisspeptin failed to stimulate GnRH expres-
sion, but GnRH stimulated the expression of kisspeptin
(Figs. 3 and 4). These observations suggest that, unlike
in the hypothalamus, kisspeptin does not govern GnRH
expression in placental cells. Although it is unknown
whether GnRH activates kisspeptin-expressing neurons in
the hypothalamus, GnRH could interact with kisspeptin-
positive cells and regulate kisspeptin expression in the
placenta.
In addition, it was revealed that stimulation of placen-
tal cells with NKB significantly increased both GnRH
and kisspeptin mRNA expression (Figs. 3 and 4). NKB is
a 10-amino-acid peptide belonging to the family of
tachykinin-related peptides, such as substance P and
neurokinin A, and NKB has neurotransmitter and neu-
romodulatory activities [38]. NKB is also expressed in
the placenta and is thought to be involved in parturition
because placental NKB mRNA levels increase at preterm
labor [39] and NKB levels increase in maternal blood
throughout pregnancy and decrease rapidly after delivery
[40]. In addition, the high expression of NKB mRNA in
chorionic villous samples at 11 weeks of gestation could
be a significant marker for pre-eclampsia [41]. Consider-
ing previous observations, our current results implied
that the NKB produced within the placenta plays some
role in placental formation and it functions in cooper-
ation with GnRH and kisspeptin.
Although a stimulatory effect of estradiol on GnRH and
kisspeptin expression was observed in placental cells, it
also stimulated hCG expression in these cells (Fig. 5a). In
addition, we found that kisspeptin and GnRH can also
stimulate hCG expression in placental cells. Furthermore,
NKB stimulated hCG mRNA expression to a greater de-
gree than either kisspeptin or GnRH (Fig. 5b). Previous
studies hypothesized that the GnRH produced within the
placenta might be involved in the autocrine/paracrine
regulation of hCG biosynthesis [11, 42]. After kisspeptin
expression was identified in the placenta, placental kis-
speptin was proposed to play a role in the regulation of
placental formation, and was defined as an inhibitor of
trophoblast invasion and proliferation [15, 43]. On the
contrary, the serum levels of hCG reportedly peaked
around 8 weeks of gestation and decreased progressively
with the concomitant increase in the serum levels of kis-
speptin [44]. At present, the detailed mechanism by which
neuropeptides, such as kisspeptin, GnRH, and NKB, in-
crease hCG synthesis and why they could increase hCG
expression in placental cells remain unknown. However,
considering the observation that the increase of hCG
mRNA expression by GnRH and kisspeptin was not
drastic, they might exert only a partial effect on hCG bio-
synthesis in the placenta. Further studies are required to
examine the control of hCG expression by these neuro-
peptides in placental cells.
Conclusions
Our experiments using primary cultures of rat placental
cells showed that GnRH, kisspeptin, and NKB expres-
sion was enhanced by estradiol, and unlike in the hypo-
thalamus, kisspeptin did not control the expression of
GnRH in placental cells. NKB might be located upstream
of kisspeptin and GnRH, and these neuropeptides might be
involved in the induction of hCG expression in placental
cells. The interaction of kisspeptin, GnRH, and NKB and
their function in placental cells are summarized in Fig. 6.
The axons of kisspeptin-positive neurons in the hypo-
thalamus form dense capillary plexuses at the site of
GnRH neurosecretion, and close contacts between
kisspeptin-positive and GnRH-positive axons have been
demonstrated [45]. As placental cells that produce GnRH,
kisspeptin, and NKB are not neuronal cells, these neuro-
peptides are considered to interact in an autocrine/
Fig. 6 Schematic summary of the present study. Hypothalamic
peptides, GnRH, kisspeptin, and NKB, were detected in primary
cultures of placental cells. All of these peptides were up-regulated
by estradiol (E2). GnRH expression was not regulated by kisspeptin,
but was regulated by GnRH itself and NKB. Kisspeptin expression
was up-regulated by GnRH and NKB. All of these neuropeptides
increased hCG expression in placental cells
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paracrine manner in the placenta. Neuropeptides pro-
duced within the placenta might work under different
mechanisms of control to those in the hypothalamus. As
it is evident that estrogens, such as estradiol and estrone,
are produced within the placenta [12], we could speculate
that the estrogens produced within the placenta might in-
crease or maintain these peptide hormones by both auto-
crine and paracrine mechanisms and maintain hCG
expression.
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